Next Article in Journal
Effect of Pharmacogenetics on Renal Outcomes of Heart Failure Patients with Reduced Ejection Fraction (HFrEF) in Response to Dapagliflozin
Next Article in Special Issue
Design of Polycation-Functionalized Resveratrol Nanocrystals for Intranasal Administration
Previous Article in Journal
Enhancing the Solubility and Oral Bioavailability of Trimethoprim Through PEG-PLGA Nanoparticles: A Comprehensive Evaluation of In Vitro and In Vivo Performance
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(8), 958; https://doi.org/10.3390/pharmaceutics17080958
Action Date Notes Link
article pdf uploaded. 24 July 2025 15:18 CEST Version of Record https://www.mdpi.com/1999-4923/17/8/958/pdf-vor
article xml file uploaded 28 July 2025 11:30 CEST Original file -
article xml uploaded. 28 July 2025 11:30 CEST Update -
article pdf uploaded. 28 July 2025 11:30 CEST Updated version of record https://www.mdpi.com/1999-4923/17/8/958/pdf-vor
article html file updated 28 July 2025 11:31 CEST Original file -
article xml file uploaded 31 July 2025 10:28 CEST Update -
article xml uploaded. 31 July 2025 10:28 CEST Update https://www.mdpi.com/1999-4923/17/8/958/xml
article pdf uploaded. 31 July 2025 10:28 CEST Updated version of record https://www.mdpi.com/1999-4923/17/8/958/pdf
article html file updated 31 July 2025 10:29 CEST Update https://www.mdpi.com/1999-4923/17/8/958/html
Back to TopTop